• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

Share:

October 1, 2020

Highlights on this story:
  • Innovators’ “NuvaWave™” launches a medical-grade, intelligent handheld UVC device that can kill the SARS-CoV-2, the virus that causes COVID-19 in two seconds.
  • Initially, the founders created it for hospitals but it’s going on the market for commercial use – offices, gyms, hotels, airlines, voting booths – everywhere it’s needed so we can get back to life.

UV Innovators, an ultraviolet technology company has unveiled NuvaWave, one of the most advanced tool in the fight against deadly pathogens. NuvaWave is a UVC handheld device that is used to disinfect any high touch surface. This product release is timely as all businesses, schools, municipalities, airlines, cruise ships and other commercial ventures need to have a solution to protect their employees, students, customers, and family from COVID-19.

NuvaWave Development

Initially, the founders created it for hospitals but it’s going on the market for commercial use – offices, gyms, hotels, airlines, voting booths – everywhere it’s needed so we can get back to life. NuvaWave was tested at Texas Biomed, an independent, nonprofit research institute whose mission is to protect our global community from the threats of infectious diseases through cutting-edge research. The results from the rigorous study completed at Texas Biomedical Research Institute demonstrated that NuvaWave killed >99.9% of the live virus in just two seconds.

For nearly three-quarters of a century, the Institute has delivered high quality and reliable scientific data, spanning basic discovery through preclinical development,” explained Dr. Cory Hallam, Professor and Vice President for Business Development at Texas Biomed. “The scientists at Texas Biomed know how to handle the live virus in their biosafety level 3 (BSL-3) lab and to use protocols to safely mimic real-world conditions that helped us document the effectiveness of NuvaWave,” added Dr. Nicholas Medendorp, CEO of UV Innovators. “NuvaWave .

New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

NuvaWave handheld device only weighs 1.5 pounds and provides 5,000 hours of disinfection. UV Innovators’ break-through technology changes the paradigm in making hospital-grade technology affordable. UV Innovators is announcing the NuvaWave Fleet Program starting at $199 a month that enables infection control teams a simple and affordable monthly payment.

Key Features

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Distance feedback to aid user in optimal placement

– Continuous system performance monitoring

– Embedded computer sensors for intelligent safety shut-off

– Uniform UVC light across disinfection area

– Ergonomically balanced design

– Visible light indicators of active disinfection

Why It Matters

“In order for people to feel comfortable getting back to normal, they must feel confident that the places they go are clean and free from infectious pathogens. NuvaWave is a commercial-grade solution for those who are disinfecting high-touch surfaces,” added Dr. Nicholas Medendorp, Jr., a technology leader with over two decades of LED experience and 115 patents and CEO of UV Innovators. “NuvaWave has undergone rigorous testing with accredited third-party laboratories to gauge its efficacy in killing SARS-CoV-2, the virus that causes COVID-19.,” added Dr. Medendorp.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • 7 AI systems outperforming medical experts7 AI systems outperforming medical experts
  • Capital Rx Wins Top Award at Accenture HealthTech Innovation ChallengeCapital Rx Wins Top Award at Accenture HealthTech Innovation Challenge
  • Health2Sync Partners with Novo Nordisk to Support Better Insulin UsageHealth2Sync Partners with Novo Nordisk to Support Better Insulin Usage
  • Ionis Pharmaceuticals Completes Acquisition of Akcea TherapeuticsIonis Pharmaceuticals Completes Acquisition of Akcea Therapeutics
  • MIT Researchers’ AI Model Detects COVID-19 By Listening to CoughsMIT Researchers’ AI Model Detects COVID-19 By Listening to Coughs
  • Aratana Therapeutics’ Stockholders Adopt Merger Agreement with Elanco Animal HealthAratana Therapeutics’ Stockholders Adopt Merger Agreement with Elanco Animal Health
  • Vanderbilt University Medical Center to Create A Precision Medicine Trial Network Focused on Critical IllnessVanderbilt University Medical Center to Create A Precision Medicine Trial Network Focused on Critical Illness
  • Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA AntibodiesCuris Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications